Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice-Reference-Cited by-同舟云学术

Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice

Published:2015-12-01 Issue:12 Volume:10 Page:e0143833
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

van Vliet Danique,Bruinenberg Vibeke M.,Mazzola Priscila N.,van Faassen Martijn H. J. R.,de Blaauw Pim,Kema Ido P.,Heiner-Fokkema M. Rebecca,van Anholt Rogier D.,van der Zee Eddy A.,van Spronsen Francjan J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Phenylketonuria;N Blau;Lancet,2010

2. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids;WM Pardridge;Neurochem Res,1998

3. Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?;FJ van Spronsen;J Inherit Metab Dis,2009

4. Transport of glutamate and other amino acids at the blood-brain barrier;QR Smith;J Nutr,2000

5. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria;GM Knudsen;J Inherit Metab Dis,1995

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New findings about neuropathological outcomes in the PKU mouse throughout lifespan;Molecular Genetics and Metabolism;2024-09

2. A 12-month, longitudinal, intervention study examining a tablet protein substitute preparation in the management of tyrosinemia;Molecular Genetics and Metabolism Reports;2024-09

3. Management of patients with phenylketonuria (PKU) under enzyme replacement therapy: An Italian model (expert opinion);Molecular Genetics and Metabolism Reports;2024-06

4. The ketogenic diet as a treatment paradigm for neurological disease;Reference Module in Neuroscience and Biobehavioral Psychology;2024

5. Postnatal hyperglycemia alters amino acid profile in retinas (model of Phase I ROP);iScience;2023-10